Delivery Order SPE2DR25D2005-SPE2DR26FF1W2
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $137,948.52 by the Defense Logistics Agency's Medical Supply Chain division. The competitively awarded, firm fixed-price contract has a completion date of November 28, 2025, and represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $22,535.80 by the Defense Logistics Agency's Medical Supply Chain on January 26, 2026. This contract represents a firm fixed-price delivery order with an ultimate completion date of January 27, 2026, and was competitively awarded without a set-aside designation. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $1,760.66 for Breynia 160-4.5 microgram inhalation solution (10.3 grams) on January 14, 2026, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The award represents a task order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $107,383.43 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. This delivery order is executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $11,267.90 by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 21, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $88,982.40 on January 20, 2026, by the Defense Logistics Agency Medical Supply Chain. The contract is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of January 21, 2026, and carries no set-aside designation. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,977.50 by the Defense Logistics Agency's Medical Supply Chain on October 1, 2025. This firm fixed price contract, designated as a child order under a larger indefinite delivery vehicle, carries an ultimate completion date of October 2, 2025. The award was made through full and open competition with no set-aside designation. As a critical pharmaceutical distributor for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $108,810 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with completion expected by June 3, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply products to support federal medical procurement needs. The award is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,590.98 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, represents a competitively awarded, non-set-aside contract. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1W2Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for AIRSUPRA 90-80 microgram inhalation solution (10.7 grams) by the Defense Logistics Agency with a ceiling value of $5,279.20. The contract was competitively awarded on January 27, 2026, with an ultimate completion date of January 28, 2026, under firm fixed-price terms. This delivery order is non-set-aside, meaning it was open to full and open competition. The award utilizes AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The Defense Logistics Agency, which administers the federal medical supply chain for the Department of Defense, relies on major pharmaceutical distributors like AmerisourceBergen to supply critical medications and medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen operates through its parent company Cencora, Inc. (formerly AmerisourceBergen), which holds multiple indefinite delivery contracts with federal agencies including the Department of Veterans Affairs and the Department of Justice Federal Bureau of Investigation. The firm's federal contract portfolio demonstrates its capability to efficiently deliver a diverse array of pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders, supporting the broader federal healthcare procurement mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 1/26/26 |